Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Baron

Showing results (111-120 of 129) with videos related to

Pageof 13
Sort By:
Hybridoma|June 1, 1997
Monoclonal antibodies specific for peptide epitopes of the epidermal growth factor receptor's extracellular domainA T Baron, B K Huntley, J M Lafky, et al.
Nanotechnology|November 29, 2019
Kinetic study of hydrogen lateral diffusion at high temperature in a directly-bonded InP-SiO<sub>2</sub>/Si substrateC Besancon, F Fournel, L Sanchez, et al.
International Journal of Particle Therapy|July 1, 2022
Vaginal Sparing Radiotherapy Using IMPT and Daily Dilator Placement for Women with Anal CancerScott C Lester, Laura A McGrath, Rachael M Guenzel, et al.
Future Medicinal Chemistry|March 16, 2012
EGFR/HER-targeted therapeutics in ovarian cancerJason A Wilken, Tayf Badri, Sarah Cross, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and womenA T Baron, J M Lafky, V J Suman, et al.
Cancer Investigation|May 1, 2013
Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancerIwona Podzielinski, Brook A Saunders, Kimberly D Kimbler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancerAndre T Baron, Elsa M Cora, Jacqueline M Lafky, et al.
The Journal of Urology|September 18, 2007
Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort studyAndrew M Harris, Bradley W Warner, John M Wilson, et al.
Diagnostics (Basel, Switzerland)|February 3, 2016
Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung AdenocarcinomaAbby L Cosentino-Boehm, Jacqueline M Lafky, Tammy M Greenwood, et al.
Cancer Treatment and Research|September 19, 2009
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancerAndre T Baron, Jacqueline M Lafky, Cecelia H Boardman, et al.
Pageof 13

Showing results (111-120 of 129) with videos related to

Sort By:
Pageof 13
Hybridoma|June 1, 1997
Monoclonal antibodies specific for peptide epitopes of the epidermal growth factor receptor's extracellular domainA T Baron, B K Huntley, J M Lafky, et al.
Nanotechnology|November 29, 2019
Kinetic study of hydrogen lateral diffusion at high temperature in a directly-bonded InP-SiO<sub>2</sub>/Si substrateC Besancon, F Fournel, L Sanchez, et al.
International Journal of Particle Therapy|July 1, 2022
Vaginal Sparing Radiotherapy Using IMPT and Daily Dilator Placement for Women with Anal CancerScott C Lester, Laura A McGrath, Rachael M Guenzel, et al.
Future Medicinal Chemistry|March 16, 2012
EGFR/HER-targeted therapeutics in ovarian cancerJason A Wilken, Tayf Badri, Sarah Cross, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 9, 2001
A preliminary study of serum concentrations of soluble epidermal growth factor receptor (sErbB1), gonadotropins, and steroid hormones in healthy men and womenA T Baron, J M Lafky, V J Suman, et al.
Cancer Investigation|May 1, 2013
Apolipoprotein concentrations are elevated in malignant ovarian cyst fluids suggesting that lipoprotein metabolism is dysregulated in epithelial ovarian cancerIwona Podzielinski, Brook A Saunders, Kimberly D Kimbler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 13, 2003
Soluble epidermal growth factor receptor (sEGFR/sErbB1) as a potential risk, screening, and diagnostic serum biomarker of epithelial ovarian cancerAndre T Baron, Elsa M Cora, Jacqueline M Lafky, et al.
The Journal of Urology|September 18, 2007
Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort studyAndrew M Harris, Bradley W Warner, John M Wilson, et al.
Diagnostics (Basel, Switzerland)|February 3, 2016
Soluble Human Epidermal Growth Factor Receptor 2 (sHER2) as a Potential Risk Assessment, Screening, and Diagnostic Biomarker of Lung AdenocarcinomaAbby L Cosentino-Boehm, Jacqueline M Lafky, Tammy M Greenwood, et al.
Cancer Treatment and Research|September 19, 2009
Soluble epidermal growth factor receptor: a biomarker of epithelial ovarian cancerAndre T Baron, Jacqueline M Lafky, Cecelia H Boardman, et al.
Pageof 13